Home › Esophageal Cancer › Texas › Irving
Esophageal Cancer clinical trials in Irving, TX
4 studies for Esophageal Cancer are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RecruitingPhase 1
- NEXT Dallas, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Dallas, Irving
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- US Oncology Investigational Product Center (IPC), Irving
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- Next Oncology Dallas /ID# 276254, Irving
About Esophageal Cancer
Early esophageal cancer does not have symptoms. Factors that increase risk include heavy drinking and smoking. Learn how you can reduce your risk.
More about Esophageal Cancer on MedlinePlus
Esophageal Cancer trials in other cities
- Houston, TX36 studies
- Boston, MA23 studies
- New York City, NY22 studies
- Nashville, TN19 studies
- St. Louis, MO17 studies
- Los Angeles, CA15 studies
- Pittsburgh, PA15 studies
- Baldwin Park, CA14 studies
- Grand Rapids, MI14 studies
- Philadelphia, PA13 studies
- San Antonio, TX12 studies
- Dallas, TX11 studies
Other studies in Irving
- Non-Small Cell Lung Cancer22 studies
- Cancer (all types)15 studies
- Colorectal Cancer13 studies
- Metastatic Cancer11 studies
- Pancreatic Cancer7 studies
- Stomach Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Lung Cancer6 studies
- Small Cell Lung Cancer6 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Triple-Negative Breast Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.